Search company, investor...

Predict your next investment

Private Equity

Investments

11

Portfolio Exits

1

About Junson Capital

Junson Capital (佳辰资本) is a private equity real estate investment firm.

Headquarters Location

Hong Kong

Want to inform investors similar to Junson Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Junson Capital News

China’s Worg Pharmaceuticals Raises ~USD58m Series B Led by Junson Capital, Lapam Capital, Kaitai Capital, Puhua Capital and Anji Ruixing Capital

Sep 20, 2022

INDUSTRY NEWS China’s Worg Pharmaceuticals Raises ~USD58m Series B Led by Junson Capital, Lapam Capital, Kaitai Capital, Puhua Capital and Anji Ruixing Capital September 14, 2022 Source(s): ChinaVenture Worg Pharmaceuticals, a China-based biopharmaceutical company developing allergy and autoimmune treatments, raised a CNY400m (~USD58m) Series B led by Junson Capital, Lapam Capital, Kaitai Capital, Puhua Capital and Anji Ruixing Capital. Read more Sign up

Junson Capital Investments

11 Investments

Junson Capital has made 11 investments. Their latest investment was in Worg Pharmaceuticals as part of their Series B on September 9, 2022.

CBI Logo

Junson Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/14/2022

Series B

Worg Pharmaceuticals

$57.46M

No

5

7/27/2022

Series B

BridGene Biosciences

$38.5M

Yes

1

5/26/2022

Series A

Full-Life

$37M

Yes

8

7/21/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

1/18/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/14/2022

7/27/2022

5/26/2022

7/21/2021

1/18/2021

Round

Series B

Series B

Series A

Series A

Series A

Company

Worg Pharmaceuticals

BridGene Biosciences

Full-Life

Subscribe to see more

Subscribe to see more

Amount

$57.46M

$38.5M

$37M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

1

8

10

10

Junson Capital Portfolio Exits

1 Portfolio Exit

Junson Capital has 1 portfolio exit. Their latest portfolio exit was Apollomics on September 14, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/14/2022

Acq - Pending

$99M

1

Date

9/14/2022

Exit

Acq - Pending

Companies

Valuation

$99M

Acquirer

Sources

1

Junson Capital Team

1 Team Member

Junson Capital has 1 team member, including current Chief Executive Officer, Kevin Liu.

Name

Work History

Title

Status

Kevin Liu

Chief Executive Officer

Current

Name

Kevin Liu

Work History

Title

Chief Executive Officer

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.